A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 1,465 shares of MDXG stock, worth $11,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,465
Previous 20,625 92.9%
Holding current value
$11,412
Previous $122 Million 88.44%
% of portfolio
0.0%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$5.51 - $9.75 $105,571 - $186,810
-19,160 Reduced 92.9%
1,465 $14.1 Million
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $102,813 - $141,208
18,197 Added 749.46%
20,625 $122 Million
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $32,684 - $42,872
-5,306 Reduced 68.61%
2,428 $16.8 Million
Q1 2024

May 15, 2024

BUY
$7.61 - $8.63 $58,855 - $66,744
7,734 New
7,734 $59.6 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $885M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.